发明名称 DRUG SELECTION FOR BREAST CANCER THERAPY USING ANTIBODY-BASED ARRAYS
摘要 PROBLEM TO BE SOLVED: To provide compositions and methods for detecting activation states of components of signal transduction pathways in tumor cells.SOLUTION: The method includes incubating a cellular extract with a plurality of beads specific for an extracellular domain (ECD) binding region of a full-length receptor, and is used to detect presence of a truncated receptor, where the truncated receptor is p95ErbB2 and the full-length receptor is ErbB2 (HER-2). Information on the activation states of components of signal transduction pathways can be used for cancer diagnosis and prognosis and for designing cancer treatments.
申请公布号 JP2013174616(A) 申请公布日期 2013.09.05
申请号 JP20130102165 申请日期 2013.05.14
申请人 NESTEC SA 发明人 SINGH SHARAT;JEANNE HARVEY;KIM PHILLIP;LIU XINJUN;LIU LIMIN;ROBERT BARHAM;BRUCE NERI
分类号 G01N33/53;C12M1/34;C12Q1/26;C12Q1/54;G01N33/543;G01N37/00 主分类号 G01N33/53
代理机构 代理人
主权项
地址